SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-010063
Filing Date
2022-05-16
Accepted
2022-05-16 16:02:50
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scph-20220331.htm   iXBRL 10-Q 1617417
2 EX-10.1 scph-ex10_1.htm EX-10.1 51228
3 EX-31.1 scph-ex31_1.htm EX-31.1 17111
4 EX-32.1 scph-ex32_1.htm EX-32.1 13185
  Complete submission text file 0000950170-22-010063.txt   7251652

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scph-20220331_lab.xml EX-101.LAB 409721
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scph-20220331_pre.xml EX-101.PRE 298089
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scph-20220331.xsd EX-101.SCH 46237
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scph-20220331_def.xml EX-101.DEF 146046
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scph-20220331_cal.xml EX-101.CAL 49110
62 EXTRACTED XBRL INSTANCE DOCUMENT scph-20220331_htm.xml XML 1498645
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38293 | Film No.: 22928613
SIC: 2834 Pharmaceutical Preparations